市場調査レポート

商品コード

1422777

ウェアラブル注射器の世界市場：タイプ別、ユーザビリティ別、技術別、治療法別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Wearable Injectors Market Assessment, By Type, By Usability, By Technology, By Therapy, By End-User, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年02月12日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 221 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のウェアラブル注射器の市場規模は、2024年～2031年の予測期間中に11.6％のCAGRで拡大し、2023年の82億3,000万米ドルから2031年には198億米ドルに成長すると予測されています。ウェアラブル注射器の世界市場拡大の原動力となっているのは、ドラッグデリバリーシステムの進歩、継続的な投薬が必要な慢性疾患の罹患率の上昇、患者の自己投与志向の高まり、長時間のドラッグデリバリーに対するウェアラブル注射器の利便性など、数多くの要素です。さらに、在宅医療への注目の高まりと、侵襲性の低いドラッグデリバリー方法への要望が、世界のウェアラブル注射器市場の成長をさらに後押ししています。

世界のウェアラブル注射器市場の大幅な成長については、ヘルスケアツールの技術的進歩が極めて重要な推進力となっています。小型化、接続性の強化、使い勝手の向上など、ウェアラブル注射器の設計における開発は、薬剤の投与方法を変革し、患者の満足度と治療へのアドヒアランスを高めています。さらに、定期的な注射を必要とする慢性疾患の増加も、世界のウェアラブル注射器市場の拡大を後押ししています。糖尿病、自己免疫疾患、心血管疾患などの疾患では、一貫した投薬が義務付けられており、ウェアラブル注射器の需要に拍車をかけています。これらのデバイスは、処方された療法を提供するための便利で管理しやすいアプローチを提示し、患者がより効率的に自分の健康を管理する力を与えます。

さらに、薬剤の自己投与への傾斜が、世界のウェアラブル注射器市場の勢いを加速させています。ウェアラブル注射器は、患者が自律的に治療を処理する力を与え、自立性を育み、定期的な注射のためのヘルスケア施設の必要性を低減します。この動向は、患者中心のヘルスケアに向けた包括的な動きと一致しており、オーダーメイドで利用しやすく効果的な医療ソリューションを重視しています。さらに、ウェアラブル注射器が提供する投与量の正確さと、通院を抑制する能力は、市場の拡大に大きく貢献しています。これらのデバイスは、投与量の正確な送達を保証し、治療効果を改善すると同時に、医療システムへの負担を軽減し、頻繁な通院に伴う患者の不便さを軽減します。

当レポートでは、世界のウェアラブル注射器市場について調査し、市場の概要とともに、タイプ別、ユーザビリティ別、技術別、治療法別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 3. Global Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 4. Global Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 5. Global Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 6. Global Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 7. Global Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 8. Global Wearable Injectors Market Share (%), By Region, 2017-2031F
Figure 9. North America Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 11. North America Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 12. North America Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 13. North America Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 14. North America Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 15. North America Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 16. North America Wearable Injectors Market Share (%), By Country, 2017-2031F
Figure 17. United States Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 19. United States Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 20. United States Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 21. United States Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 22. United States Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 23. United States Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 24. Canada Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 26. Canada Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 27. Canada Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 28. Canada Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 29. Canada Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 30. Canada Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 33. Mexico Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 34. Mexico Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 35. Mexico Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 36. Mexico Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 37. Mexico Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 38. Europe Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 40. Europe Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 41. Europe Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 42. Europe Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 43. Europe Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 44. Europe Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 45. Europe Wearable Injectors Market Share (%), By Country, 2017-2031F
Figure 46. Germany Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 48. Germany Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 49. Germany Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 50. Germany Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 51. Germany Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 52. Germany Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 53. France Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 55. France Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 56. France Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 57. France Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 58. France Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 59. France Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 60. Italy Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 62. Italy Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 63. Italy Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 64. Italy Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 65. Italy Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 66. Italy Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 69. United Kingdom Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 70. United Kingdom Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 71. United Kingdom Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 72. United Kingdom Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 73. United Kingdom Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 74. Russia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 76. Russia Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 77. Russia Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 78. Russia Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 79. Russia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 80. Russia Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 81. Netherlands Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 83. Netherlands Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 84. Netherlands Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 85. Netherlands Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 86. Netherlands Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 87. Netherlands Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 88. Spain Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 90. Spain Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 91. Spain Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 92. Spain Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 93. Spain Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 94. Spain Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 95. Turkey Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 97. Turkey Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 98. Turkey Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 99. Turkey Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 100. Turkey Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 101. Turkey Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 102. Poland Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 104. Poland Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 105. Poland Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 106. Poland Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 107. Poland Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 108. Poland Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 109. South America Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 111. South America Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 112. South America Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 113. South America Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 114. South America Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 115. South America Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 116. South America Wearable Injectors Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 119. Brazil Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 120. Brazil Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 121. Brazil Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 122. Brazil Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 123. Brazil Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 124. Argentina Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 126. Argentina Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 127. Argentina Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 128. Argentina Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 129. Argentina Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 130. Argentina Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 131. Asia-Pacific Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 133. Asia-Pacific Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 134. Asia-Pacific Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 135. Asia-Pacific Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 136. Asia-Pacific Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 137. Asia- Pacific Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 138. Asia-Pacific Wearable Injectors Market Share (%), By Country, 2017-2031F
Figure 139. India Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 141. India Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 142. India Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 143. India Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 144. India Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 145. India Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 146. China Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 148. China Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 149. China Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 150. China Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 151. China Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 152. China Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 153. Japan Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 155. Japan Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 156. Japan Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 157. Japan Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 158. Japan Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 159. Japan Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 160. Australia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 162. Australia Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 163. Australia Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 164. Australia Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 165. Australia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 166. Australia Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 167. Vietnam Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 169. Vietnam Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 170. Vietnam Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 171. Vietnam Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 172. Vietnam Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 173. Vietnam Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 174. South Korea Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 176. South Korea Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 177. South Korea Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 178. South Korea Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 179. South Korea Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 180. South Korea Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 181. Indonesia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 183. Indonesia Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 184. Indonesia Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 185. Indonesia Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 186. Indonesia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 187. Indonesia Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 188. Philippines Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 190. Philippines Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 191. Philippines Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 192. Philippines Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 193. Philippines Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 194. Philippines Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 195. Middle East & Africa Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 197. Middle East & Africa Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 198. Middle East & Africa Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 199. Middle East & Africa Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 200. Middle East & Africa Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 201. Middle East & Africa Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 202. Middle East & Africa Wearable Injectors Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 205. Saudi Arabia Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 206. Saudi Arabia Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 207. Saudi Arabia Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 208. Saudi Arabia Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 209. Saudi Arabia Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 210. UAE Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 212. UAE Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 213. UAE Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 214. UAE Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 215. UAE Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 216. UAE Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 217. South Africa Wearable Injectors Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Wearable Injectors Market, By Volume, In Millions, 2017-2031F
Figure 219. South Africa Wearable Injectors Market Share (%), By Type, 2017-2031F
Figure 220. South Africa Wearable Injectors Market Share (%), By Usability, 2017-2031F
Figure 221. South Africa Wearable Injectors Market Share (%), By Technology, 2017-2031F
Figure 222. South Africa Wearable Injectors Market Share (%), By Therapy, 2017-2031F
Figure 223. South Africa Wearable Injectors Market Share (%), By End-user, 2017-2031F
Figure 224. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Usability Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Therapy Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX10975

Global wearable injectors market is projected to witness a CAGR of 11.6% during the forecast period 2024-2031, growing from USD 8.23 billion in 2023 to USD 19.8 billion in 2031. Numerous elements drive the expansion of the global wearable injectors market, including advancements in drug delivery systems, the escalating incidence of chronic illnesses needing ongoing medication heightened patient inclination toward self-administration, and the convenience of wearable injectors for prolonged drug delivery. Moreover, the increasing focus on home healthcare and the desire for less invasive drug delivery methods further propel the growth of the global wearable injectors market.

The substantial growth of the global wearable injectors market stems from a convergence of critical factors. Technological advancements in healthcare tools stand as a pivotal driver. Developments in wearable injector designs, including downsizing, connectivity enhancements, and improved user-friendliness, have transformed how drugs are administered, elevating patient satisfaction and adherence to treatments. Additionally, the rising occurrence of chronic illnesses requiring regular injections propels the expansion of the global wearable injectors market. Diseases like diabetes, autoimmune conditions, and cardiovascular disorders mandate consistent medication, spurring the demand for wearable injectors. These devices present a convenient, easily manageable approach to deliver prescribed therapies, empowering patients to take charge of their health more efficiently.

Moreover, the inclination towards self-administering medications amplifies the momentum of the global wearable injectors market. Wearable injectors empower patients to autonomously handle their treatments, fostering independence and reducing the need for healthcare facilities for routine injections. This trend aligns with the overarching movement towards patient-centered healthcare, emphasizing tailored, accessible, and effective medical solutions. Furthermore, the precision in dosing offered by wearable injectors and their ability to curtail hospital visits significantly contribute to market expansion. These devices ensure accurate delivery of dosages, improving treatment effectiveness, while easing the strain on healthcare systems and diminishing patient inconvenience associated with frequent clinic visits, which, in turn, is propelling the rapid growth of the global wearable injectors market.

Self-Administrative Drugs

The surge in demand for self-administered medications is a key catalyst propelling the global wearable injectors market expansion. This heightened need arises from several factors, notably the changing healthcare landscape where patients increasingly desire autonomy and convenience in managing their therapies. Empowering individuals through self-administration allows for greater control and flexibility in managing one's health. Furthermore, with the escalating prevalence of chronic diseases globally, there's a heightened necessity for continuous medication, driving the requirement for patient-centric drug delivery systems that are easy to use. Wearable injectors seamlessly integrate into this paradigm, providing a user-friendly interface for patients to self-administer medications. These devices boost patient adherence and cater to the growing preference for home-based healthcare solutions. The amalgamation of patient convenience, treatment control, and the simplicity of wearable injectors significantly fuels their adoption, fostering substantial growth in the global market.

Technological Advancements

Cutting-edge technologies, such as IQ (Intelligent Quality), are pivotal in driving the growth of the global wearable injectors market. By integrating intelligent features, IQ technology transforms drug delivery systems, guaranteeing precise dosing, heightened safety, and an improved user experience. These advancements not only enhance patient confidence but also promote adherence to treatments. IQ technology offers real-time monitoring, connectivity, and personalized dosing, which substantially advances wearable injector capabilities. Its integration effectively meets essential healthcare demands, fueling market expansion through the delivery of efficient, dependable, and patient-focused solutions.

The Tandem Mobi insulin delivery system, for example, was approved by the US Food and Drug Administration (FDA) in July 2023. Tandem Diabetes Care is a US-based diabetes technology firm. The device has been branded the "world's smallest insulin pump" by the manufacturer, and its full release is anticipated in the later parts of 2024. People with type 1 diabetes can employ Tandem Mobi's control-IQ technology, a hybrid-closed loop algorithm, starting at age six.

Government Initiatives

Governments globally are proactively launching programs and policies to improve the viability of injectors, stimulating the growth of the global wearable injectors market. These strategies span various actions, from funding research and development to facilitating innovative-friendly regulatory frameworks and implementing programs that enhance the accessibility and affordability of wearable injector technology. These collective endeavors create a favorable environment for incorporating these devices within healthcare systems. By strengthening feasibility and promoting widespread adoption, governmental initiatives play a substantial role in driving the rapid expansion of the global wearable injectors market.

For example, in July 2023, Bruce Fitch, the Health Minister, announced the expansion of insulin health programme to lower the cost of insulin pumps for Brunswick residents. Patients with type 1 diabetes who were above 25 years old could now use the gadget. The prevalence of diabetes is rising by 23% in New Brunswick. The announcement, which eliminates the age limit for insulin pumps, is a crucial component of a larger strategy for which the government has provided a sizeable amount of funds.

Growing Popularity of Insulin Patch

There's a notable rise in the global demand for insulin patches within the wearable injectors market. These patches offer a non-invasive, inconspicuous, and user-friendly approach to insulin delivery, catering to patients seeking alternatives to traditional injections. Their user convenience, combined with technological advancements, ensuring precise dosing and prolonged usage, strongly resonates with individuals managing diabetes. As diabetes rates escalate worldwide and there's an increased focus on improving patient experiences and adherence to treatments, insulin patches have emerged as a highly sought-after choice. Their appeal primarily lies in delivering continuous insulin without hassle, thereby fueling their increasing prominence in the global wearable injectors market.

For instance, in October 2023, Enable Injections, Inc. announced that the EMPAVELI Injector (enFuse) was approved by the U.S. Food and Drug Administration (FDA) for the subcutaneous delivery of EMPAVELI (pegcetacoplan), which is sold to adults with paroxysmal nocturnal hemoglobinuria (PNH) by Apellis Pharmaceuticals, Inc. in the United States. The EMPAVELI Injector is a wearable, small injector that is intended to simplify self-administration, while causing the least amount of disturbance to patients' everyday routines.

Wearable Injectors for Diabetes

Wearable injectors play a substantial role in the field of diabetes care, profoundly impacting the global market for such devices. These tools provide a convenient and user-friendly way to administer insulin, improving treatment adherence and patient comfort in diabetes management. Given the increasing global incidence of diabetes and the growing focus on personalized patient care, wearable injectors have become a favored insulin delivery method. Their precision in dosing, ease of use, and suitability for continuous therapies perfectly meets the needs of diabetes management, leading to their widespread adoption and driving the expansion.

For example, in November 2023, ViCentra launched a closed-loop diabetes solution in Europe by integrating an insulin pump with Dexcom and Diabeloop technology. The insulin pump is from ViCentra, the CGM is a Dexcom G6 sensor, and Diabeloop created the algorithm. In hybrid closed-loop systems, the output of an insulin pump is adjusted as needed during the day by use of an algorithm that first analyses real-time blood sugar readings from a continuous glucose monitor.

Future Market Scenario (2024-2031F)

The outlook for the global wearable injectors market is promising, driven by several pivotal factors. To begin, ongoing technological advancements continually enhance these devices, rendering them more user-friendly, precise, and adaptable to diverse therapeutic requirements. Secondly, the escalating incidence of chronic illnesses necessitating continuous treatment, coupled with the shift towards personalized healthcare, escalates the demand for wearable injectors. Furthermore, as healthcare systems worldwide prioritize cost-effectiveness and patient-centered care, these devices seamlessly cater to these objectives by offering convenience, bolstering treatment adherence and enabling remote monitoring. Moreover, the expansion of wearable injectors beyond conventional medications to encompass biologics and larger therapeutic molecules creates new opportunities for their utilization. Additionally, supportive governmental initiatives and increased investments in research and development (R&D) significantly contribute to the growth of the global wearable injectors market. This convergence of factors propels wearable injectors towards a promising future, set to revolutionize drug delivery and enhance global patient outcomes.

Key Players Landscape and Outlook

Major participants in the global wearable injectors market are actively engaging in mergers and acquisitions. These strategic endeavors focus on consolidating market presence, improving technological prowess and diversifying product arrays. Mergers allow firms to leverage synergies, merging skills and resources to pioneer and introduce cutting-edge solutions. Acquisitions provide entry into new markets, technologies, or intellectual property, fostering competitive edges. Such actions streamline operations, optimize distribution networks, and expedite market entry. Overall, these strategic initiatives among leading corporations signify a collective drive to fortify market standings, spur innovation, and address the evolving needs of consumers in the wearable injectors sector.

For example, in May 2023, the world-renowned healthcare technology giant Medtronic plc announced that it has signed a series of final agreements to buy EOFlow Co. Ltd., the company that makes the EOPatch, an insulin delivery device that is totally disposable, wearable, and tubeless. The integration of EOFlow with Medtronic's Meal Detection Technology algorithm and next-generation continuous glucose monitor (CGM) is anticipated to increase the company's capacity to cater to the requirements of a greater number of diabetes patients, irrespective of their insulin delivery preferences or treatment status.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Wearable Injectors Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. Value
- 4.1.2. Volume
4.2. By Type
- 4.2.1. Patch Pump/Injectors
- 4.2.2. Infusion Pump/Injectors
4.3. By Usability
- 4.3.1. Disposable
- 4.3.2. Reusable
4.4. By Technology
- 4.4.1. Motor Based
- 4.4.2. Expanding Battery
- 4.4.3. Rotary Pump
- 4.4.4. Spring Based
- 4.4.5. Others
4.5. By Therapy
- 4.5.1. Diabetes
- 4.5.2. Autoimmune
- 4.5.3. Cardiovascular
- 4.5.4. Neurological
- 4.5.5. Oncological
- 4.5.6. Others
4.6. By End-User
- 4.6.1. Hospitals and Clinics
- 4.6.2. Home Healthcare Setting
4.7. By Region
- 4.7.1. North America
- 4.7.2. Europe
- 4.7.3. South America
- 4.7.4. Asia-Pacific
- 4.7.5. Middle East and Africa
4.8. By Company Market Share (%), 2023

5. Global Wearable Injectors Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. Value
  - 5.1.1.2. Volume
- 5.1.2. By Type
  - 5.1.2.1. Patch Pump/Injectors
  - 5.1.2.2. Infusion Pump/Injectors
- 5.1.3. By Usability
  - 5.1.3.1. Disposable
  - 5.1.3.2. Reusable
- 5.1.4. By Technology
  - 5.1.4.1. Motor Based
  - 5.1.4.2. Expanding Battery
  - 5.1.4.3. Rotary Pump
  - 5.1.4.4. Spring Based
  - 5.1.4.5. Others
- 5.1.5. By Therapy
  - 5.1.5.1. Diabetes
  - 5.1.5.2. Autoimmune
  - 5.1.5.3. Cardiovascular
  - 5.1.5.4. Neurological
  - 5.1.5.5. Oncological
  - 5.1.5.6. Others
- 5.1.6. By End-User
  - 5.1.6.1. Hospitals and Clinics
  - 5.1.6.2. Home Healthcare Setting
- 5.1.7. United States*
  - 5.1.7.1. Market Size & Forecast
  - 5.1.7.1.1. Value
  - 5.1.7.1.2. Volume
  - 5.1.7.2. By Type
  - 5.1.7.2.1. Patch Pump/Injectors
  - 5.1.7.2.2. Infusion Pump/Injectors
  - 5.1.7.3. By Usability
  - 5.1.7.3.1. Disposable
  - 5.1.7.3.2. Reusable
  - 5.1.7.4. By Technology
  - 5.1.7.4.1. Motor Based
  - 5.1.7.4.2. Expanding Battery
  - 5.1.7.4.3. Rotary Pump
  - 5.1.7.4.4. Spring Based
  - 5.1.7.4.5. Others
  - 5.1.7.5. By Therapy
  - 5.1.7.5.1. Diabetes
  - 5.1.7.5.2. Autoimmune
  - 5.1.7.5.3. Cardiovascular
  - 5.1.7.5.4. Neurological
  - 5.1.7.5.5. Oncological
  - 5.1.7.5.6. Others
  - 5.1.7.6. By End-User
  - 5.1.7.6.1. Hospitals and Clinics
  - 5.1.7.6.2. Home Healthcare Setting
- 5.1.8. Canada
- 5.1.9. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. South America
- 5.3.1. Brazil
- 5.3.2. Argentina
5.4. Asia-Pacific
- 5.4.1. India
- 5.4.2. China
- 5.4.3. Japan
- 5.4.4. Australia
- 5.4.5. Vietnam
- 5.4.6. South Korea
- 5.4.7. Indonesia
- 5.4.8. Philippines
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Type
6.2. By Usability
6.3. By Technology
6.4. By Therapy
6.5. By End-User
6.6. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Enable Injections, Inc.
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. SteadyMed Therapeutics, Inc.
13.3. Johnson & Johnson Services, Inc.
13.4. CeQur SA.
13.5. West Pharmaceutical Services, Inc.
13.6. Unilife Corporation
13.7. F. Hoffmann-La Roche Ltd.
13.8. Becton, Dickinson and Company
13.9. Amgen, Inc.
13.10. Insulet Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

ウェアラブル注射器の世界市場：タイプ別、ユーザビリティ別、技術別、治療法別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Wearable Injectors Market Assessment, By Type, By Usability, By Technology, By Therapy, By End-User, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のウェアラブル注射器市場の見通し、2017年～2031年

第5章世界のウェアラブル注射器市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Wearable Injectors Market Outlook, 2017-2031F

5. Global Wearable Injectors Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

ウェアラブル注射器の世界市場：タイプ別、ユーザビリティ別、技術別、治療法別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Wearable Injectors Market Assessment, By Type, By Usability, By Technology, By Therapy, By End-User, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のウェアラブル注射器市場の見通し、2017年～2031年

第5章 世界のウェアラブル注射器市場の見通し、地域別、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 お問合せと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Wearable Injectors Market Outlook, 2017-2031F

5. Global Wearable Injectors Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のウェアラブル注射器市場の見通し、2017年～2031年

第5章世界のウェアラブル注射器市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制の枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章お問合せと免責事項